Sanofi Pasteur, a Sanofi Company

Related records

Trials (432)

• 36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds
• A Digital Flu Intervention for People With Cardiovascular Conditions
• A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 Years
• A Phase I, Randomized, Modified Single-blind, Active-controlled (Infants Only), Four-stage, Step-down, Comparative, Multi-center Study
• A Safety and Immune Response Study of 2 Experimental HIV Vaccines
• A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China
• A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults
• A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers
• A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers
• A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly
• A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years
• A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants
• A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults
• A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age
• A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years
• A Study of Influenza Virus Vaccines in Children and Adults
• A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers
• A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly
• A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months
• A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine